enVVeno Medical Corporation NVNO
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.47% | -3.02% | 17.69% | 32.19% | -48.66% |
| Total Depreciation and Amortization | -76.61% | 5.98% | -2.50% | -7.69% | 6.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.48% | -28.21% | -1.51% | -52.27% | 80.24% |
| Change in Net Operating Assets | -1,370.37% | 95.00% | 22.86% | -152.79% | 375.10% |
| Cash from Operations | -9.60% | 5.95% | 21.61% | -18.22% | 7.54% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 32.38% | -33.76% | 14.54% | 29.15% | -45.65% |
| Cash from Investing | 32.38% | -33.76% | 14.54% | 29.38% | -45.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 224.48% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 224.48% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 152.14% | -130.77% | 404.20% | 44.01% | -175.49% |